Cognition Therapeutics Financial Overview
Cognition Therapeutics's market cap is currently $128.88M. The company's EPS TTM is $-0.06; its P/E ratio is -3.16; Cognition Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
